Daisy Sanchez1, Derek Dubay2, Baliga Prabhakar3, David J Taber2,4. 1. College of Medicine, MUSC, Charleston, SC, 29425, USA. sanched@musc.edu. 2. Department of Transplant Surgery, MUSC, Charleston, SC, USA. 3. College of Medicine, MUSC, Charleston, SC, 29425, USA. 4. Ralph H Johnson, VAMC, Charleston, SC, USA.
Abstract
INTRODUCTION: To improve kidney transplant allocation equitability, a new Kidney Allocation System (KAS) was implemented December 4, 2014. The purpose of this study was to determine if the impact of KAS on peri-operative outcomes differed by recipient race/ethnicity. METHODS: This was a time series analysis using data aggregated in monthly intervals from October 2012 through September 2015 using the University HealthSystem Consortium (UHC). This includes national data aggregated at the center level of all US kidney transplant centers that participate in the UHC (416 centers). Segmented regression with interaction terms was used to determine the impact of KAS on outcomes and differences by race/ethnicity. RESULTS: A total of 28,809 deceased donor kidney transplants were included with 25 months of pre-KAS data and 10 months of post-KAS data. After KAS implementation, the estimated transplant rate per month decreased significantly for Caucasians by 17.6 cases per month (p = 0.0001), and increased significantly for AAs by 37.8 (p = 0.0001), Hispanics by 16.3 (p = 0.0001), and other races by 8.2 cases per month (p = 0.0001). Delayed graft function, 7- and 14-day readmissions significantly increased after KAS, which did not differ by race. Hispanics saw a 7.7% decrease in ICU admissions after KAS, which differed as compared to other racial/ethnic cohorts (p = 0.0026). Costs of kidney transplantation increased significantly after KAS in all groups except Hispanics. Mortality, length of stay, in-hospital complications, and 30-day readmissions were not significantly impacted by KAS, also not differing by race/ethnicity. CONCLUSION: KAS had substantial impact on transplant rates by race/ethnicity. KAS also led to increased costs, readmissions, and delayed graft function (DGF) across all racial/ethnic groups. The impact of KAS on ICU cases solely within Hispanics requires further investigation into potential etiologies.
INTRODUCTION: To improve kidney transplant allocation equitability, a new Kidney Allocation System (KAS) was implemented December 4, 2014. The purpose of this study was to determine if the impact of KAS on peri-operative outcomes differed by recipient race/ethnicity. METHODS: This was a time series analysis using data aggregated in monthly intervals from October 2012 through September 2015 using the University HealthSystem Consortium (UHC). This includes national data aggregated at the center level of all US kidney transplant centers that participate in the UHC (416 centers). Segmented regression with interaction terms was used to determine the impact of KAS on outcomes and differences by race/ethnicity. RESULTS: A total of 28,809 deceased donor kidney transplants were included with 25 months of pre-KAS data and 10 months of post-KAS data. After KAS implementation, the estimated transplant rate per month decreased significantly for Caucasians by 17.6 cases per month (p = 0.0001), and increased significantly for AAs by 37.8 (p = 0.0001), Hispanics by 16.3 (p = 0.0001), and other races by 8.2 cases per month (p = 0.0001). Delayed graft function, 7- and 14-day readmissions significantly increased after KAS, which did not differ by race. Hispanics saw a 7.7% decrease in ICU admissions after KAS, which differed as compared to other racial/ethnic cohorts (p = 0.0026). Costs of kidney transplantation increased significantly after KAS in all groups except Hispanics. Mortality, length of stay, in-hospital complications, and 30-day readmissions were not significantly impacted by KAS, also not differing by race/ethnicity. CONCLUSION: KAS had substantial impact on transplant rates by race/ethnicity. KAS also led to increased costs, readmissions, and delayed graft function (DGF) across all racial/ethnic groups. The impact of KAS on ICU cases solely within Hispanics requires further investigation into potential etiologies.
Authors: J F Neylan; M H Sayegh; T M Coffman; G M Danovitch; A M Krensky; T B Strom; L A Turka; W E Harmon Journal: J Am Soc Nephrol Date: 1999-10 Impact factor: 10.121
Authors: David J Taber; Derek DuBay; John W McGillicuddy; Satish Nadig; Charles F Bratton; Kenneth D Chavin; Prabhakar K Baliga Journal: J Am Coll Surg Date: 2017-01-31 Impact factor: 6.113
Authors: John J Friedewald; Ciara J Samana; Bertram L Kasiske; Ajay K Israni; Darren Stewart; Wida Cherikh; Richard N Formica Journal: Surg Clin North Am Date: 2013-12 Impact factor: 2.741
Authors: R A Bray; P Brannon; C Breitenbach; C Bryan; D-F Chen; J Lai; T McRacken; A Kirk; B Kaplan; T Pearson; H M Gebel Journal: Am J Transplant Date: 2014-11-17 Impact factor: 8.086
Authors: David J Taber; John W McGillicuddy; Charles F Bratton; Angello Lin; Kenneth D Chavin; Prabhakar K Baliga Journal: J Am Coll Surg Date: 2013-12-24 Impact factor: 6.113
Authors: Howard M Gebel; Bertram L Kasiske; Sally K Gustafson; Joshua Pyke; Eugene Shteyn; Ajay K Israni; Robert A Bray; Jon J Snyder; John J Friedewald; Dorry L Segev Journal: Clin J Am Soc Nephrol Date: 2016-02-02 Impact factor: 8.237
Authors: Ajay K Israni; Nicholas Salkowski; Sally Gustafson; Jon J Snyder; John J Friedewald; Richard N Formica; Xinyue Wang; Eugene Shteyn; Wida Cherikh; Darren Stewart; Ciara J Samana; Adrine Chung; Allyson Hart; Bertram L Kasiske Journal: J Am Soc Nephrol Date: 2014-05-15 Impact factor: 10.121
Authors: Jill Krissberg; Matthew Kaufmann; Anshal Gupta; Eran Bendavid; Margaret Stedman; Xingxing Cheng; Jane Tan; Paul Grimm; Abanti Chaudhuri Journal: Clin J Am Soc Nephrol Date: 2021-10-20 Impact factor: 8.237
Authors: Tiffany R Hodges; Collin M Labak; Uma V Mahajan; Christina Huang Wright; James Wright; Gino Cioffi; Haley Gittleman; Eric Z Herring; Xiaofei Zhou; Kelsey Duncan; Carol Kruchko; Andrew E Sloan; Jill S Barnholtz-Sloan Journal: Neurooncol Adv Date: 2021-03-06